Showtime is Making Billions: Hollywood's Latest Stab at Wall Street

Chance Finance  |

With so much material to work with, it's a wonder why Hollywood has never really gotten Wall Street right for the TV-viewing public. The world of high finance is furtile ground for dramatic boardroom politics, indulgent glamour lifestyles of the rich, and hostile empire-building via aggressive mergers and acquisitions. Yet with all that, we'd still venture to guess that most people would be hard-pressed to name any shows they remember. Some names that you may have never heard of include Fox's The $treet, which starred Jennifer Connolly and a few other people big-ish in the '90s; TNT's Bull, which apparently existed; and MOJO HD's Wall Street Warriors, which was more quirky reality TV than scripted drama. The $treet and Bull failed to make it past their first seasons, and Wall Street Warriors moved onto the web for its third and final season after MOJO shut down.

But as investors always say, past performance is not an indicator of future performance, and Showtime's Billions is making a bet that it'll break through that resistance. The show, which is expected to premiere in 2016, has no shortage of star power either. Damian Lewis plays hedge funder and f**k-you-money haver Bobby Axelrod while Paul Giamatti plays his foil as US Attorney Chuck Rhoades. Malin Akerman, Maggie Siff and David Costabile roundout a pretty impressive cast.

But if that doesn't float your boat, Billions seems to be just the first of a few upcoming shows about the financial markets. CBS, Fox and Sony are all reportedly working on their own versions. Considering that we're more than five years removed from the Great Recession, maybe viewers have once again regained the stomach for appointment viewing of the rich on their TVs. Watch the trailer below.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:



Symbol Last Price Change % Change










Q BioMed CEO provides a Corporate Update

Denis Corin, CEO of Q BioMed Inc. ”Q“, a biomedical acceleration and development company, focused on licensing and acquiring undervalued biomedical assets in the healthcare sector, provides a corporate update.

Emerging Growth

Goldrea Resources Corp.

Goldrea Resources Corp is engaged in the acquisition, exploration and development of mineral properties located in North America.